Yamaguchi, Japan

Kiyomi Ishida

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Gmbh. Active years: 2013.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyomi Ishida: Innovator in Pharmaceutical Solutions

Introduction

Kiyomi Ishida is a notable inventor based in Yamaguchi, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the delivery and efficacy of medications.

Latest Patents

Kiyomi Ishida holds a patent for a "Ciclesonide containing sterile aqueous suspension." This invention relates to a sterile aqueous suspension that includes ciclesonide, a microgel, and a water-soluble ionic polymer. The invention provides a sterile aqueous suspension in which ciclesonide is dispersed homogeneously over a long period of time. This advancement is crucial for improving the stability and effectiveness of the medication.

Career Highlights

Kiyomi Ishida is currently employed at Takeda GmbH, a leading global pharmaceutical company. Her role involves research and development, where she applies her expertise to create innovative solutions for various health challenges. Her dedication to her work has positioned her as a key player in her field.

Collaborations

Kiyomi collaborates with her coworker, Susumu Maruo, who is also a talented professional in the pharmaceutical industry. Together, they work on projects that aim to push the boundaries of drug formulation and delivery systems.

Conclusion

Kiyomi Ishida's contributions to the pharmaceutical industry through her innovative patent and collaborative efforts highlight her commitment to advancing healthcare solutions. Her work continues to impact the field positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…